Survey Report : In Situ Hybridization: 2018 to 2024 | Leica Biosystems Nussloch GmbH, Thermo Fisher Scientific, F. Hoffmann-La Roche AG, Abbott Laboratories, Agilent Technologies
Press Release – 07 Aug 2018
Research and Development News --
. .
Latest Update "In Situ Hybridization: Market Shares, Strategy, and Forecasts, Worldwide, 2018 to 2024" with Industries Survey | Global Current Growth and Future.
' '
The 2018 study has 242 pages, 83 tables and figures. Worldwide markets are poised to achieve continuing growth as In Situ Hybridization is used in diagnostic situations to analyze single cells inside tissue. Managing single cell diagnostics in real time, encouraging collaborative business efforts. Lowering transaction management costs is a key benefit.
In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough (e.g., plant seeds, Drosophila embryos), in the entire tissue (whole mount ISH), in cells, and in circulating tumor cells (CTCs).
. .
– Get Sample Report_https://www.researchmoz.us/enquiry.php?type=S&repid=1657153
' '
Advances in RNA in situ hybridization transform molecular detection with morphological context enabling new applications. Scientists use RNA ISH to extract data dimensions.
Immunohistochemistry (IHC) and RNA in situ Hybridization are widely used technologies sharing the unique capacity to analyze a marker at the single cell level while preserving the morphological context. In different situations, IHC and ISH are used in conjunction to validate data or provide complementary information.
The global market for In Situ Hybridization (ISH) at $4.3 billion in 2017 is anticipated to reach $7.8 billion by 2024 2017. CAGR of 7.8% in the next five years (2017 to 2024). Increasing diagnosis and growing incidence & prevalence of cancer, technology advancements in therapeutics, increasing government initiatives globally are expected to drive the growth of the market in the coming years.
WinterGreen Research is an independent research organization funded by the sale of market research studies all over the world and by the implementation of ROI models that are used to calculate the total cost of ownership of equipment, services, and software. The company has 35 distributors worldwide, including Global Information Info Shop, Market Research.com, Research and Markets, electronics.ca, Bloomberg, and Thompson Financial.
These are all vital market research support solutions requiring trust and integrity.
Companies Profiled
Market Leaders
- Leica Biosystems Nussloch GmbH
- Thermo Fisher Scientific
- F. Hoffmann-La Roche AG
- Abbott Laboratories
- Agilent Technologies
- PerkinElmer
- Qiagen / Exiqon A/S
- Merck KGaA
- BioGenex Laboratories
- BioTechne / Advanced Cell Diagnostics (ACD)
. .
– More Clear Details get Full Table of Contents_https://www.researchmoz.us/in-situ-hybridization-market-shares-strategy-and-forecasts-worldwide-2018-to-2024-report.html/toc
' '
Key Topics
- In Situ Hybridization
- Molecular Diagnostics
- Cervical Cancer Stain
- Fish Steps Reduction
- Fluorescence In Situ Hybridization (FISH)
- In Situ Hybridization (ISH)
- FISH Probe Kit
- Cancer
- Chromosonal Abnormalities
- Infectious Diseases
- Inflammatory Diseases
Continue.....
About Researchmoz,
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
--Researchmoz Global Pvt. Ltd.--
Mr. Nachiket G.
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074
www.researchmoz.us
Research and Development News --
. .
Latest Update "In Situ Hybridization: Market Shares, Strategy, and Forecasts, Worldwide, 2018 to 2024" with Industries Survey | Global Current Growth and Future.
' '
The 2018 study has 242 pages, 83 tables and figures. Worldwide markets are poised to achieve continuing growth as In Situ Hybridization is used in diagnostic situations to analyze single cells inside tissue. Managing single cell diagnostics in real time, encouraging collaborative business efforts. Lowering transaction management costs is a key benefit.
In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough (e.g., plant seeds, Drosophila embryos), in the entire tissue (whole mount ISH), in cells, and in circulating tumor cells (CTCs).
. .
– Get Sample Report_https://www.researchmoz.us/enquiry.php?type=S&repid=1657153
' '
Advances in RNA in situ hybridization transform molecular detection with morphological context enabling new applications. Scientists use RNA ISH to extract data dimensions.
Immunohistochemistry (IHC) and RNA in situ Hybridization are widely used technologies sharing the unique capacity to analyze a marker at the single cell level while preserving the morphological context. In different situations, IHC and ISH are used in conjunction to validate data or provide complementary information.
The global market for In Situ Hybridization (ISH) at $4.3 billion in 2017 is anticipated to reach $7.8 billion by 2024 2017. CAGR of 7.8% in the next five years (2017 to 2024). Increasing diagnosis and growing incidence & prevalence of cancer, technology advancements in therapeutics, increasing government initiatives globally are expected to drive the growth of the market in the coming years.
WinterGreen Research is an independent research organization funded by the sale of market research studies all over the world and by the implementation of ROI models that are used to calculate the total cost of ownership of equipment, services, and software. The company has 35 distributors worldwide, including Global Information Info Shop, Market Research.com, Research and Markets, electronics.ca, Bloomberg, and Thompson Financial.
These are all vital market research support solutions requiring trust and integrity.
Companies Profiled
Market Leaders
- Leica Biosystems Nussloch GmbH
- Thermo Fisher Scientific
- F. Hoffmann-La Roche AG
- Abbott Laboratories
- Agilent Technologies
- PerkinElmer
- Qiagen / Exiqon A/S
- Merck KGaA
- BioGenex Laboratories
- BioTechne / Advanced Cell Diagnostics (ACD)
. .
– More Clear Details get Full Table of Contents_https://www.researchmoz.us/in-situ-hybridization-market-shares-strategy-and-forecasts-worldwide-2018-to-2024-report.html/toc
' '
Key Topics
- In Situ Hybridization
- Molecular Diagnostics
- Cervical Cancer Stain
- Fish Steps Reduction
- Fluorescence In Situ Hybridization (FISH)
- In Situ Hybridization (ISH)
- FISH Probe Kit
- Cancer
- Chromosonal Abnormalities
- Infectious Diseases
- Inflammatory Diseases
Continue.....
About Researchmoz,
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
--Researchmoz Global Pvt. Ltd.--
Mr. Nachiket G.
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074
www.researchmoz.us
Comments
Post a Comment